Natroba is currently approved by the Food and Drug Administration as a cure for head lice and scabies in the U.S. and Cipher said that many treatments currently in Canada have lost effectiveness ...

Important milestone towards public reimbursement for a new treatment option for eligible Canadian patients living with moderate to severe hidradenitis suppurativa (HS) Following this important ...

On November 22, 2024, the pan-Canadian Pharmaceutical Alliance (pCPA) released its 2023-2024 impact report. According to the pCPA, estimated dollar savings for public drug plans from pCPA negotiations ...

Eligible Canadian patients with heterozygous familial hypercholesterolemia (HeFH) are one step closer to publicly funded access to cholesterol lowering treatment. MONTRÉAL, Aug. 21, 2025 /CNW/ - ...

Specialized Niches Drive Growth – Companies like Knight Therapeutics, Viemed Healthcare, and HLS Therapeutics thrive by focusing on specific markets, whether it’s licensing under-served drugs, home ...

From established players to up-and-coming firms, Canada's pharmaceutical landscape is diverse and dynamic. Canadian drug companies are working to discover and develop major innovations amidst an ...

Dr. Chase Family of Care announces Minard’s Liniment— the 160-year-old Maritime pain relief formula—has officially ...

TORONTO—Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to new research findings from the University of Toronto. Applying 25 ...

MONTREAL, April 14, 2025 /CNW/ -- Paladin Pharma is pleased to announce the successful completion of negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public funding of ...